These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29119732

  • 1. Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation.
    Zhu J, Gao RJ, Liu Q, Jiang RH, Yu L, Sun YX, Zhang P, Lin JW, Ye Y, Zhang ZW, Chen SQ, Cheng H, Sheng X, Jiang CY.
    J Zhejiang Univ Sci B; ; 18(11):946-954. PubMed ID: 29119732
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Vamos M, Cappato R, Marchlinski FE, Natale A, Hohnloser SH.
    Europace; 2016 Dec; 18(12):1787-1794. PubMed ID: 26797248
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
    Xing Y, Xu B, Xu C, Peng F, Yang B, Qiu Y, Sun Y, Wang S, Guo H.
    Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
    [Abstract] [Full Text] [Related]

  • 9. Asymptomatic Cerebral Infarction During Catheter Ablation for Atrial Fibrillation: Comparing Uninterrupted Rivaroxaban and Warfarin (ASCERTAIN).
    Kimura T, Kashimura S, Nishiyama T, Katsumata Y, Inagawa K, Ikegami Y, Nishiyama N, Fukumoto K, Tanimoto Y, Aizawa Y, Tanimoto K, Fukuda K, Takatsuki S.
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1598-1609. PubMed ID: 30573125
    [Abstract] [Full Text] [Related]

  • 10. Rivaroxaban for Periprocedural Anticoagulation Therapy in Japanese Patients Undergoing Catheter Ablation of Paroxysmal Non-Valvular Atrial Fibrillation.
    Kawabata M, Sasaki T, Maeda S, Shirai Y, Yamauchi Y, Nitta J, Goya M, Hirao K.
    Int Heart J; 2016 Dec 02; 57(6):712-716. PubMed ID: 27818480
    [Abstract] [Full Text] [Related]

  • 11. Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
    Li PJ, Xiao J, Yang Q, Feng Y, Wang T, Liu GJ, Liang ZA.
    J Interv Card Electrophysiol; 2016 Sep 02; 46(3):213-24. PubMed ID: 27001171
    [Abstract] [Full Text] [Related]

  • 12. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M.
    J Med Econ; 2015 Jun 02; 18(6):399-409. PubMed ID: 25586203
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A.
    Am J Cardiol; 2014 Aug 15; 114(4):577-82. PubMed ID: 24998087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Breithardt G, ROCKET AF Steering Committee & Investigators.
    J Am Coll Cardiol; 2013 May 14; 61(19):1998-2006. PubMed ID: 23500298
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.